The Envision Health Consulting Difference
Envision Health Consultant Pharmacists are skilled health care professionals who have specialized training in the medication-related needs of seniors. Envision Health Consultants complete comprehensive consultations that provide thorough, review of each resident’s medications — prescription, over-the-counter, herbal, and nutritional. Envision Health Consultants are experts in the regulatory requirements for Skilled and Assisted Living, as well as behavioral health and correctional facilities and have experience aiding facilities in obtaining JACHO certification as well preventing survey issues.
Educational Services
Besides being the leader in pharmacy consulting services, Envision Health Consulting also offers continuing education for not only pharmacists but nursing professionals and healthcare administrators as well.
Envision Health Consulting currently offers a large number of classes of continuing education which includes a wide array of topics including the state required, Medication Errors and Human Trafficking. Envision will gladly come to your place of business and set up classes for your staff as well as one on one instruction. Both local and regional programs are also available.
Long Term Care & Clinical Consulting
Envision Health Consulting prides itself on being a leader in Skilled Nursing and Assisted Living Consultant Services and goes well beyond the mandatory services. Our pharmacists provide visit reports based on the findings of each inspection.
Our recommendations are individualized to each resident and delivered directly to the facility and prescriber. We also provide a summary of recommendations for easy tracking. All Consultant reports are posted to this website for HIPAA secure access by the pharmacy and the facility any time 24/7.
“Our goal is to provide the BEST pharmacy consultant care to facility residents, and provide all facility, medical staffs, and provider pharmacies with the best level of support possible”
Latest News
View our latest news and updates!
Eli Lilly’s rheumatoid arthritis medication Olumiant (baricitinib) may be the next treatment for COVID-19, thanks to AI analysis
Eli Lilly’s rheumatoid arthritis medication, Olumiant (baricitinib), is currently in phase 3 clinical trials to become a potential drug used...
Read MoreBy: Samuel Won, PharmD Candidate 2021
According to the Centers for Disease Control and Prevention (CDC), elderly patients are at increased risk of complications and death...
Read MoreA Peptide to Increase Lifespan and Decrease Age-Related Diseases
Human longevity. Long have men sought to predict or control their own lifespans or improve their vitalities. Many cultures have...
Read MoreCoronavirus breakthrough: dexamethasone is first drug shown to save lives
A breakthrough has been discovered in one of the world’s biggest randomized, controlled trials for coronavirus treatment. Based in the...
Read MoreFDA Approves First Drug for Imaging Tau Pathology in Alzheimer’s Disease
Tauvid (flortaucipir F18) was recently approved for intravenous injection during PET imaging of for patients being evaluated for Alzheimer’s disease...
Read MoreThe Effect of Personality Traits on Risk of Incident Pre‐dementia Syndromes
An intriguing new study was published this month in The Journal of the American Geriatrics Society, proposing that personality traits...
Read MoreThis Just In: FDA Approves Antibiotic to Treat Hospital-Acquired (HAP) and Ventilator-Acquired (VAP) Bacterial Pneumonia
On June 4th, 2020 the FDA approved Recarbrio (imipenem-cilastatin and relebactam) to treat HAP/VAP in patients over 18 years old....
Read MoreCMS Guidelines for Nursing Home Visits Post-COVID
It goes without saying that patients at nursing homes and other long term care facilities are at the most risk...
Read MoreFDA Authorizes First Standalone At-Home Sample Collection Kit for COVID-19 Diagnostic Testing
The FDA has officially authorized the first at-home sample collection kit that can be sent off to two different laboratories...
Read MoreArthritis and its Connection to Cardiovascular Disease
Of people aged 65 years or older, 49.6% have reported doctor-diagnosed arthritis according to a 2015 national survey conducted by...
Read More